Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 16, 2020
Vishnu Dwadasi has joined Pii as the head of the company’s Project Management Office.
read more
Wednesday, December 02, 2020
Jay Feldman has joined Pharmaceutics International, Inc. (Pii) as the Head of Information Technology.
read more
Pii announced the expansion of its commercial team with the additions of Wayne Ideus, Wayne Grellner and Ryan McFarlane.
read more
Pierre Fabre announced a purchase agreement to acquire several assets from biotechnology company Igenica Biotherapeutics.
read more
Monday, December 08, 2014
This award is recognition of both Pierre Fabre's expertise in dermatology, one of its development priorities, and of its ability to form public-private partnerships, such as that established with the University of Bordeaux.
read more
PierianDx announced a strategic partnership with RTI International to help solve the problem of translating complex genomic data into actionable clinical insight to advance precision medicine
read more
Wednesday, November 29, 2017
Phyton Biotech has received a grant from the Bill & Melinda Gates Foundation to fund research and development of an alternative method of producing artemisinin.
read more
Eight physician groups sent a letter to U.S. Food and Drug Administration (FDA) Commissioner Stephen Ostroff underscoring the need to ensure that biosimilar product labeling contains all needed data for physicians to make appropriate prescribing ...
read more
Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VI performance goals letter.
read more
Sunday, September 18, 2016
Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl issued the following statement on the release of the Biosimilar User Fee Act (II) performance goals letter.
read more
Wednesday, February 01, 2017
The Pharmaceutical Research and Manufacturers of America (PhRMA) board of directors has elected new officers and welcomed a new member company.
read more
Monday, February 04, 2019
The Pharmaceutical Research and Manufacturers of America (PhRMA) elected three new officers to its board of directors.
read more
The Pharmaceutical Research and Manufacturers of America (PhRMA) appointed new leadership to its board of directors.
read more
Wednesday, December 09, 2015
America’s biopharmaceutical companies are currently developing 190 medicines to treat heart disease and stroke, according to a new report released from the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Association of Black ...
read more
Wednesday, September 09, 2020
PhoreMost and XtalPi have entered into a drug discovery collaboration agreement. Financial details are not disclosed.
read more